Medica-Plus: A Micromegas-based proof-of-concept detector for sub-becquerel tritium activity assessment at the service of oncological research

F. Jambon,S. Aune,P. Baron,T. Benoit,T. Bey,D. Desforge,E. Ferrer-Ribas, A. Grabas,M. Kebbiri,I. Mandjavidze,T. Papaevangelou,M. Riallot,M. Vandenbroucke,F. Beau, V. Dive,C. Malgorn,F. Malloggi, A. Rousselot,F. Carrel, M. Trocmé

Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment（2022）

Cited 2|Views27

No score

Abstract

To fulfil needs in oncological research a new Micromegas detector has been developed to follow radiolabelled drugs in living organisms at the single cell level. This article describes the proof-of-concept of such a detector and compares its ability to detect and assess sub-becquerel 3H activities with a commercial β-imager.

Translated text

Key words

MPGD,Micromegas,3H radiolabelling

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined